Daily non-political popular news in brief.

Biodegradable microspheres deliver time release vaccines, stimulate different immune response

A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not. Researchers from Iowa State University report their findings today at the ASM Biodefense and Emerging Disease Research Meeting.

Read more »

Keywords: biodegradable, microspheres, deliver, time, release, vaccines, stimulate, different, immune, response, microsphere, vaccine

« Previous | Next »

Similar news on "Biodegradable microspheres deliver time release vaccines, stimulate different immune response":

1. Virus used to create experimental HIV vaccines directly impairs the immune response
   11-15-2007 · EurekAlert!
   Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at the Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.
   Similar news · Read more »
   
2. Chronic HIV-1 infection frequently fails to protect against superinfection
   11-15-2007 · EurekAlert!
   Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published Nov. 16 in PLoS Pathogens. The team of researchers show how HIV-1 vaccines may not be as reliable against superinfection as once thought. This study suggests that immune responses found in natural HIV-1 infection may not be the best path to an effective HIV-1 vaccine.
   Similar news · Read more »
   
3. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
4. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
   04-30-2007 · EurekAlert!
   In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.
   Similar news · Read more »
   
5. New target for HIV/AIDS drugs and vaccine discovered
   07-26-2007 · EurekAlert!
   Researchers from Rome, Italy, describe a finding in the August 2007 print issue of the FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the body's innate immune system.
   Similar news · Read more »
   
6. Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine
   04-15-2007 · EurekAlert!
   Experimental vaccines to help the immune system fight tumors have rarely been designed to directly stimulate helper T cells, one of the body's most critical immune responders, because of the difficult process required to isolate and clone antigens for vaccine development. Now, a new technique may allow scientists to create a melanoma vaccine able to stimulate helper T cells. The approach may also aid in the development of other vaccines against cancers or infectious diseases.
   Similar news · Read more »
   
7. Head and neck cancer vaccine targets proteins to create immune response
   04-17-2007 · EurekAlert!
   Researchers at the University of Pittsburgh Cancer Institute, in collaboration with the Gunma University School of Medicine in Japan, have developed a vaccine strategy for head and neck cancer that targets multiple peptides to activate the immune system to attack tumors. Their findings will be included in a press briefing on cancer vaccines at the annual meeting of the American Association for Cancer Research, April 14-18, at the Los Angeles Convention Center.
   Similar news · Read more »
   
8. Chronic infection persists by targeting stromal cell network in lymphoid organs
   09-18-2007 · EurekAlert!
   One of the biggest challenges to treating infectious diseases and developing preventive vaccines is the ability of many chronic infections to suppress the immune T-cell response over time. An Emory-led team of scientists has discovered one important way in which chronic viral infections are able to evade the immune response by infecting a type of stromal cells in the lymphoid organs called fibroblastic reticular cells.
   Similar news · Read more »
   
9. MRSA vaccine shows promise in mouse study
   10-30-2006 · EurekAlert!
   By combining the four bacterial surface proteins that generate the strongest immune response in mice, researchers at the University of Chicago have created a vaccine that significantly protects immunized animals from multiple disease-causing, drug-resistant strains of Staphylococcus aureus, the most common cause of hospital-acquired infections and a rapidly spreading source of community-associated illness.
   Similar news · Read more »
   
10. Early Start: Fetuses generate immune response to vaccination
    06-02-2007 · Science News Online
    A fetus can manufacture immune cells and antibodies in direct response to vaccine given to the mother during pregnancy.
    Similar news · Read more »